Merck's (MRK) monoclonal antibody clesrovimab shows cuts RSV infections by 60% in infants, with a strong safety profile. Read ...

RSV is a virus that can make people sick, especially older adults and babies. But even though RSV can be serious, people aren ...

WellSpan Ephrata Community Hospital is now offering respiratory syncytial virus immunizations to infants born at the hospital ...

RSV, or Respiratory Syncytial Virus, is a highly contagious virus that frequently spreads among preschool children, ...

Respiratory virus season is underway, but Washington is more prepared than it was last year to protect against some severe ...

Clesrovimab (MK-1654), an Investigational RSV Monoclonal Antibody, Significantly Reduced Incidence of RSV Disease and ...

Cold and flu season — otherwise known as mid-October — is upon us. But this year, several advancements in vaccines could help ...

Respiratory Illness season is right around the corner and experts are urging parents to take action to protect their newborns ...

MOBILE, Ala. ( WALA) - At USA Health Children’s & Women’s Hospital, doctors are seeing a rise in pediatric RSV cases. Dr.

Merck’s investigational antibody clesrovimab demonstrated more than 60% effectiveness in reducing some types of respiratory ...

Health experts highlight how this highly contagious disease affects vulnerable populations and share insights on prevention ...

Public worry about getting RSV has dropped significantly since the fall of 2023, though RSV remains a concern for infants and ...